Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204759
Company: KETTERING MEDCTR

Products on ANDA 204759

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
FLUDEOXYGLUCOSE F18	FLUDEOXYGLUCOSE F-18	4-40mCi/ML	INJECTABLE;INTRAVENOUS	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 204759

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/27/2015	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 204759

FLUDEOXYGLUCOSE F18

INJECTABLE;INTRAVENOUS; 4-40mCi/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
FLUDEOXYGLUCOSE F18	FLUDEOXYGLUCOSE F-18	4-40mCi/ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	204759	KETTERING MEDCTR
FLUDEOXYGLUCOSE F18	FLUDEOXYGLUCOSE F-18	4-40mCi/ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	203811	UCLA BIOMEDICAL